Will Bolus for Beignets - Part 1: Candid Conversations from ADA

Hosted by Nancy Hanna and Dena Gottesman

The guest on this episode has an ongoing commercial relationship with Insulet, and Insulet has paid a fee for their participation in this podcast.

In this episode, Nancy and Dena commence the first part of a compilation of interviews conducted at the 82nd ADA conference. These talks include topics such as exercise with closed-loop therapy with Dr. Laurel Messer, reducing stigma surrounding diabetes with Nicole Patience, and a conversation with this year’s Outstanding Educator in Diabetes Award winner, Dr. Amy-Hess Fischl

Time stamps

1:33 – Using hybrid closed-loop AID systems for exercise management and the importance of customizable and individualized strategies
6:20 – The need for diabetes stigma education on every level from patient to practitioner
9:03 – Why no one wants to see the dietician
15:32 – Transitioning adolescence with diabetes into adulthood

 

This podcast provides general information and discussions about health and related subjects. This information and other content provided in this podcast, or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. If you or any other person has a medical concern, you should consult your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that you have heard in this podcast or read in any linked materials. The opinions and views expressed on this podcast and website have no relation to those of any academic, hospital, health practice or other institution.

Please consult the Omnipod® 5 Automated Insulin Delivery System User Guide for more information.

The Omnipod 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older & type 2 diabetes in persons aged 18 years and older. The Omnipod 5 System is intended for single patient use. The Omnipod 5 System is indicated for use with NovoLog®, Humalog®, and Admelog®. Refer to the Omnipod 5 Automated Insulin Delivery System User Guide and www.omnipod.com/safety for complete safety information including indications, contraindications, warnings, cautions, and instructions. Warning: DO NOT use SmartAdjust technology for individuals under 2 years of age or use less than 5 U of insulin per day. DO NOT start to use the Omnipod 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.